BioSpace News Archive

ndivior PLC (LON: INDV) today announced the publication of one-year outcomes from a 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and Socio-Economic Factors on Recovery).

The company’s platform continues to help veterinarians maintain continuity of care for their pet and horse owner clients during this crisis

Phase III VIALE-A study showed Venclexta plus azacitidine helped people with the most common type of aggressive leukemia in adults live longer compared to azacitidine alone – – Data will be shared with global health authorities and presented at an upcoming medical meeting – SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III VIALE-A study met

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Jet-Oxide ® 15% post-harvest sanitizer and industrial disinfectant product is now allowed by the U.S. EPA for use against human coronaviruses to sanitize industrial food and agricultural hard surfaces. The allowed use was based on a study conducted by the EPA wit

ALR Technologies, Inc. announces their ALRT Diabetes Solution platform provides the tools physicians need to offer telehealth, telemedicine, and remote patient monitoring services to their patients with diabetes. The expanded reimbursements for telehealth services, recently announced by the Centers for Medicare and Medicaid Services (CMS) due to the coronavirus outbreak, is especially h

Access-Power, Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce that we have retained our new Chief Executive Officer.

Validation Institute (VI) is hosting a second one-hour webinar on Tuesday, March 24 , at 2PM ET titled, “Part II: Using Technology and Data to Reduce COVID-19 Transmission and Other Enduring Risks and Anxiety in the Conference, Hospitality, Travel, Entertainment, and Related Industries.” The March 24 Part II webinar will go in

- In the months since the global public health crisis rose from a regional crisis to a global threat, drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. The crisis has catalyzed the development of novel vaccines across

Harvard Bioscience, Inc. (Nasdaq: HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) – for academic researchers, contract research organizations (CROs) and pharmaceutical companies involved in pre-clinical inhalation and exposure studies. With our new Buxco® AIA system, researchers are presented with real-time aerosol amounts inhaled and deposited in subjects’ lungs, a breakthrough improvement over the

Ultra-fast Genetic Test For COVID-19 Created By Bay Area Lab Avellino